Literature DB >> 30528723

Clinical features and myofascial pain syndrome in older adults with knee osteoarthritis by sex and age distribution: A cross-sectional study.

Eleuterio A Sánchez-Romero1, Daniel Pecos-Martín2, Cesar Calvo-Lobo3, David García-Jiménez4, Victoria Ochoa-Sáez5, Verónica Burgos-Caballero5, Josué Fernández-Carnero6.   

Abstract

BACKGROUND: A source of myofascial pain and myofascial trigger points (MTrPs) in muscles of the knee area could play a crucial role in the management of pain in osteoarthritis patients. The aim of this study was to describe and compare demographic, clinical and myofascial pain syndrome characteristics in older adults with knee osteoarthritis by sex and age distribution.
METHODS: A cross-sectional study was carried out. 114 patients with osteoarthritis were recruited in older-adult care centers. The diagnosis of active and/or latent MTrPs (AMTrPs/LMTrPs) was performed. Numerical Pain Rating Scale, Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Barthel Index, Timed Up and Go Test (TUG), Mini-Mental State Examination, EuroQol Group 5-Dimension Self-Report Questionnaire, chronicity, number of falls, and medication use were collected. All data were compared by sex (male or female) and age (< 70, 70-80, or > 80 years) distributions.
RESULTS: The most prevalent muscles with AMTrPs and LMTrPs were the quadriceps vastus medialis (75.43%) and lateralis (65.78%), respectively. The clinical characteristics showed significant differences (P<0.05) for chronicity, WOMAC functionality and total scores, TUG, falls rate and medication between males and females, as well as for chronicity, Barthel index and TUG between age distributions. There were not any significant differences (P>0.05) by sex or age distribution according to the number and presence of active and latent MTrPs.
CONCLUSIONS: The demographic and clinical features of older adults with knee osteoarthritis may be influenced by sex and age distribution. Nevertheless, the myofascial pain syndrome associated with knee osteoarthritis did not seem to be related to sex or age distribution.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disability; Knee; Musculoskeletal disorders; Osteoarthritis; Pain; Trigger points

Mesh:

Year:  2018        PMID: 30528723     DOI: 10.1016/j.knee.2018.09.011

Source DB:  PubMed          Journal:  Knee        ISSN: 0968-0160            Impact factor:   2.199


  5 in total

Review 1.  Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria.

Authors:  Felipe C K Duarte; Daniel W D West; Lukas D Linde; Samah Hassan; Dinesh A Kumbhare
Journal:  Curr Rheumatol Rep       Date:  2021-07-08       Impact factor: 4.592

Review 2.  Effects of Trigger Point Dry Needling for the Management of Knee Pain Syndromes: A Systematic Review and Meta-Analysis.

Authors:  Youssef Rahou-El-Bachiri; Marcos J Navarro-Santana; Guido F Gómez-Chiguano; Joshua A Cleland; Ibai López-de-Uralde-Villanueva; César Fernández-de-Las-Peñas; Ricardo Ortega-Santiago; Gustavo Plaza-Manzano
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

3.  Identifying Clinical and MRI Characteristics Associated with Quality of Life in Patients with Anterior Cruciate Ligament Injury: Prognostic Factors for Long-Term.

Authors:  Eleuterio A Sánchez Romero; Tifanny Lim; José Luis Alonso Pérez; Matteo Castaldo; Pedro Martínez Lozano; Jorge Hugo Villafañe
Journal:  Int J Environ Res Public Health       Date:  2021-12-06       Impact factor: 3.390

Review 4.  Disease-Modifying Adjunctive Therapy (DMAT) in Osteoarthritis-The Biological Effects of a Multi-Mineral Complex, LithoLexal® Joint-A Review.

Authors:  Erik Fink Eriksen; Osvandre Lech; Gilberto Yoshinobu Nakama; Denise M O'Gorman
Journal:  Clin Pract       Date:  2021-11-26

5.  Predicting Venous Thrombosis in Osteoarthritis Using a Machine Learning Algorithm: A Population-Based Cohort Study.

Authors:  Chao Lu; Jiayin Song; Hui Li; Wenxing Yu; Yangquan Hao; Ke Xu; Peng Xu
Journal:  J Pers Med       Date:  2022-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.